Cargando…
A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity
BACKGROUND: AKT, a critical effector of the phosphoinositide 3-kinase (PI3K) signalling cascade, is an intensely pursued therapeutic target in oncology. Two distinct classes of AKT inhibitors have been in clinical development, ATP-competitive and allosteric. Class-specific differences in drug activi...
Autores principales: | Kostaras, Eleftherios, Kaserer, Teresa, Lazaro, Glorianne, Heuss, Sara Farrah, Hussain, Aasia, Casado, Pedro, Hayes, Angela, Yandim, Cihangir, Palaskas, Nicolaos, Yu, Yi, Schwartz, Brian, Raynaud, Florence, Chung, Yuen-Li, Cutillas, Pedro R., Vivanco, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435276/ https://www.ncbi.nlm.nih.gov/pubmed/32439931 http://dx.doi.org/10.1038/s41416-020-0889-4 |
Ejemplares similares
-
Inhibitors in AKTion: ATP-competitive vs allosteric
por: Lazaro, Glorianne, et al.
Publicado: (2020) -
Expression dynamics of repetitive DNA in early human embryonic development
por: Yandım, Cihangir, et al.
Publicado: (2019) -
Identification of differentially expressed genomic repeats in primary hepatocellular carcinoma and their potential links to biological processes and survival
por: KARAKÜLAH, Gökhan, et al.
Publicado: (2021) -
Signature changes in the expressions of protein-coding genes, lncRNAs, and repeat elements in early and late cellular senescence
por: KARAKÜLAH, Gökhan, et al.
Publicado: (2020) -
Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)